Chaney M A, Nikolov M P, Blakeman B P, Bakhos M
Department of Anesthesiology, Loyola University Medical Center, Maywood, Illinois 60513, USA.
Anesth Analg. 1999 Nov;89(5):1091-5. doi: 10.1213/00000539-199911000-00004.
We attempted to develop an insulin administration protocol that maintains normoglycemia in patients undergoing cardiac surgery and to study the effects of intraoperative blood glucose management on serum levels of creatine phosphokinase isoenzyme BB (CK-BB) and S-100 protein. Twenty nondiabetic patients were randomly allocated to receive either "tight control" of blood glucose with a standardized IV insulin infusion intraoperatively (Group TC) or "no control" of blood glucose intraoperatively (Group NC). Perioperative serum levels of glucose, CK-BB, and S-100 protein were determined in all patients. Group TC patients received 90.0 +/- 49.2 units of insulin, whereas Group NC patients received none. Despite insulin, both Group TC (P = 0.00026) and Group NC (P = 0.00003) experienced similar significant increases in blood glucose levels during hypothermic cardiopulmonary bypass. However, mean blood glucose level upon intensive care unit arrival was significantly decreased in Group TC, compared with Group NC (84.7 +/- 41.0 mg/dL, range 32-137 mg/dL vs 201.4 +/- 67.5 mg/dL, range 82-277 mg/dL, respectively; P = 0.0002). Forty percent of Group TC patients required treatment for postoperative hypoglycemia (blood glucose level <60 mg/dL). Substantial interindividual variability existed in regard to insulin resistance. The investigation was terminated after we realized that normoglycemia was unattainable with the study protocol and that postoperative hypoglycemia was unpredictable. All patients in both groups experienced similar significant increases in postoperative serum levels of CK-BB and S-100 protein. These results indicate that "tight control" of intraoperative blood glucose in nondiabetic patients undergoing cardiac surgery was unattainable with the study protocol and may initiate postoperative hypoglycemia.
The appropriate intraoperative management of hyperglycemia and whether it adversely affects neurologic outcome in patients after cardiac surgery remains controversial. This investigation reveals that attempting to maintain normoglycemia in this setting with insulin may initiate postoperative hypoglycemia.
我们试图制定一种胰岛素给药方案,以维持心脏手术患者的血糖正常,并研究术中血糖管理对血清肌酸磷酸激酶同工酶BB(CK - BB)和S - 100蛋白水平的影响。20例非糖尿病患者被随机分配,术中一组接受标准化静脉输注胰岛素进行血糖“严格控制”(TC组),另一组术中对血糖“不控制”(NC组)。测定所有患者围手术期血清葡萄糖、CK - BB和S - 100蛋白水平。TC组患者接受了90.0±49.2单位胰岛素,而NC组患者未接受胰岛素。尽管使用了胰岛素,但在低温体外循环期间,TC组(P = 0.00026)和NC组(P = 0.00003)的血糖水平均出现了类似的显著升高。然而,与NC组相比,TC组患者进入重症监护病房时的平均血糖水平显著降低(分别为84.7±41.0mg/dL,范围32 - 137mg/dL vs 201.4±67.5mg/dL,范围82 - 277mg/dL;P = 0.0002)。TC组40%的患者需要治疗术后低血糖(血糖水平<60mg/dL)。胰岛素抵抗存在很大的个体差异。在我们意识到按照研究方案无法实现血糖正常且术后低血糖不可预测后,该研究终止。两组所有患者术后血清CK - BB和S - 100蛋白水平均出现了类似的显著升高。这些结果表明,按照研究方案,在接受心脏手术的非糖尿病患者中无法实现术中血糖的“严格控制”,且可能引发术后低血糖。
高血糖的适当术中管理以及它是否会对心脏手术后患者的神经学结局产生不利影响仍存在争议。这项研究表明,在此情况下试图用胰岛素维持血糖正常可能引发术后低血糖。